Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Afinitor 5mg


Contraindicated
Reproductive toxicity in animals

Contraindicated
Afinitor 5mg :
Type Medicine Authorised
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Pharma Stein AG
Origin Switzerland
ATC L01XE10

Your comment will appear shortly after approval

Afinitor 5mg :

Revision Date : 16/12/2014


Effect Frequency
Abdominal pain Common
Acne Common
Acute respiratory distress syndrome Rare
Ageusia (Taste loss) Uncommon
Alopecia Common
ALT increased Common
Alveolitis Rare
Amenorrhoea secondary Uncommon
Anaemia Very Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Aphthous stomatitis Common
Aplasia pure red cell (PRCA) Rare
Arthralgia (Pain joint) (Joint ache) Common
Aspergillosis Not known
AST increased Common
Asthenia Very Common
Blood creatinine increased Common
Candidiasis (Candida infection) Not known
Congestive heart failure Uncommon
Conjunctivitis Uncommon
Cough Common
Decreased appetite Very Common
Deep vein thrombosis Uncommon
Dehydration Common
Diabetes mellitus Common
Diarrhoea (Diarrhea) Very Common
Dry mouth (Xerostomia) Common
Dry skin Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Common
Dysphagia Common
Dyspnoea (dyspnea) Common
Epistaxis (Nasal bleeding) Very Common
Erythema Common
Eyelid oedema Common
Fatigue Very Common
Flushing Uncommon
Glossitis Uncommon
Glossodynia Uncommon
Haemoptysis Uncommon
Haemorrhage Common
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Common
Headache Very Common
Hepatitis B reactivation Not known
Herpes zoster Uncommon
Hypercholesterolaemia Very Common
Hyperglycaemia Very Common
Hyperlipidaemia Common
Hypersensitivity Uncommon
Hypertension Common
Hypertriglyceridaemia Common
Hypocalcaemia Common
Hypokalaemia Common
Hypophosphataemia Common
Infection Very Common
Insomnia Common
Interstitial pneumonitis Common
Leucopenia (Leukopenia) Common
Lung infiltration (pulmonary infiltration) Common
Lymphopenia Common
Menstruation irregular Common
Mouth ulceration Common
Mucosal inflammation Common
Nail disorders Common
Nausea Very Common
Neutropenia Common
Non-cardiac chest pain Uncommon
Oedema peripheral Very Common
Onychoclasis Common
Opportunistic infections Not known
Oral pain Common
Pancytopenia Uncommon
Pneumocystis carinii pneumonia Not known
Pneumonia Common
Pneumonitis Very Common
Proteinuria Common
Pruritus Very Common
Pulmonary alveolar haemorrhage Rare
Pulmonary embolism Uncommon
Pulmonary toxicity Rare
Pyrexia Common
Renal failure Common
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Uncommon
Sepsis (Systemic infection) (Sepsis state) Uncommon
Skin exfoliation (Flaking skin) Common
Skin lesion Common
Skin rash Very Common
Stomatitis Very Common
Thrombocytopenia (Thrombopenia) Common
Tongue ulceration Common
Urine output increased Uncommon
Vomiting Common
Weight decreased (Weight loss) Very Common
Wound healing delayed Rare

Different Units By MoH Code

Revision Date : 07/12/2021

Revision Date : 07/12/2021

Afinitor 5mg  MoH 5897 :
Form Tablet
Packaging Blisters
Package Size Box of 30
Strength 5mg
Storage Condition <30°C protect from humidity & light
Public Price 2255578 L.L.
Stratum E2
NSSF ✔
Quarantine ✔
Reg. Number 218674/10
Submission date 01/01/2010
Registration Year 2010


Price Comparison

● Country: Italy
● Package Size: 30
● Public Price: 4021.62 EUR ( 73,917,576.68 LBP )
● Pack size unit used: 30
● Cost/Unit: 134,054 EUR ( 2,462,926.70 LBP )
● Exfactory Price: 2436.75 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 30
● Public Price: 17212 QAR ( 71,439,438.72 LBP )
● Pack size unit used: 30
● Cost/Unit: 573,7333 QAR ( 2,378,270.88 LBP )
● Pharmacy Price: 14138.43968654 QAR ( 58682442.225365 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 30
● Public Price: 1812.25 OMR ( 71,222,331.13 LBP )
● Pack size unit used: 30
● Cost/Unit: 60,4083 OMR ( 2,358,030.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: Boîte de 30
● Public Price: 1412.14 KWD ( 69,999,892.77 LBP )
● Pack size unit used: 30
● Cost/Unit: 47,0713 KWD ( 2,329,793.76 LBP )
● Pharmacy Price: 1193.02 KWD ( 59138096.8416 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 30
● Public Price: 16083.5 AED ( 66,118,625.16 LBP )
● Pack size unit used: 30
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Pharmacy Price: 13701 AED ( 56324262.96 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 30's (10's Blister x 3)
● Public Price: 16083.5 AED ( 66,118,625.16 LBP )
● Pack size unit used: 30
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Pharmacy Price: 13701.05 AED ( 56324468.508 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 30
● Public Price: 1529.82 BHD ( 61,377,556.36 LBP )
● Pack size unit used: 30
● Cost/Unit: 50,994 BHD ( 2,006,038.50 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 30
● Public Price: 14730.15 SAR ( 59,368,101.96 LBP )
● Pack size unit used: 30
● Cost/Unit: 491,005 SAR ( 1,978,916.58 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 30
● Public Price: 2535.7 JOD ( 54,112,319.78 LBP )
● Pack size unit used: 30
● Cost/Unit: 84,5233 JOD ( 1,792,575.96 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 30
● Public Price: 21403.6 DKK ( 52,673,617.49 LBP )
● Pack size unit used: 30
● Cost/Unit: 713,4533 DKK ( 1,754,671.61 LBP )
● Pharmacy Price: 15908.4 DKK ( 39150095.148 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 30
● Public Price: 2856.63 EUR ( 52,505,002.23 LBP )
● Pack size unit used: 30
● Cost/Unit: 95,221 EUR ( 1,746,104.75 LBP )
● Pharmacy Price: 2849.63 EUR ( 52376341.8815 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Germany
● Package Size: 30
● Public Price: 2810.19 EUR ( 51,651,432.71 LBP )
● Pack size unit used: 30
● Cost/Unit: 93,673 EUR ( 1,709,344.65 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: Finland
● Package Size: 30
● Public Price: 2594.72 EUR ( 47,691,083.34 LBP )
● Pack size unit used: 30
● Cost/Unit: 86,4907 EUR ( 1,580,684.30 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 30
● Public Price: 416556 ISK ( 46,179,398.16 LBP )
● Pack size unit used: 30
● Cost/Unit: 13885,2 ISK ( 1,539,291.10 LBP )
● Pharmacy Price: 329820 ISK ( 36563845.2 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: UK
● Package Size: 30
● Public Price: 2250 GBP ( 45,339,232.50 LBP )
● Pack size unit used: 30
● Cost/Unit: 75 GBP ( 1,511,307.75 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Sweden
● Package Size: 30
● Public Price: 24714.33 SEK ( 44,488,512.58 LBP )
● Pack size unit used: 30
● Cost/Unit: 823,811 SEK ( 1,481,490.53 LBP )
● Pharmacy Price: 24173.12 SEK ( 43514275.0432 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: Norway
● Package Size: 30
● Public Price: 25461.1 NOK ( 44,054,577.50 LBP )
● Pack size unit used: 30
● Cost/Unit: 848,7033 NOK ( 1,467,268.96 LBP )
● Pharmacy Price: 19941.08 NOK ( 34503452.4916 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 30
● Public Price: 2386.59 EUR ( 43,865,643.53 LBP )
● Pack size unit used: 30
● Cost/Unit: 79,553 EUR ( 1,452,023.95 LBP )
● Pricing Date: 08/10/2020
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 30 TABS
● Public Price: 2269.12 EUR ( 41,706,539.06 LBP )
● Pack size unit used: 30
● Cost/Unit: 75,6373 EUR ( 1,378,503.75 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 30
● Public Price: 57686.53 CZK ( 39,847,547.46 LBP )
● Pack size unit used: 30
● Cost/Unit: 1922,8843 CZK ( 1,327,640.72 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Greece
● Package Size: 30
● Public Price: 1919.25 EUR ( 35,275,910.96 LBP )
● Pack size unit used: 30
● Cost/Unit: 63,975 EUR ( 1,157,943.15 LBP )
● Exfactory Price: 1719.38 EUR
● Pharmacy Price: 1745.17 EUR ( 32076311.8585 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: France
● Package Size: 30
● Public Price: 1864.91 EUR ( 34,277,139.05 LBP )
● Pack size unit used: 30
● Cost/Unit: 62,1637 EUR ( 1,139,563.10 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 30
● Public Price: 1754.9 CHF ( 29,939,032.73 LBP )
● Pack size unit used: 30
● Cost/Unit: 58,4967 CHF ( 989,494.50 LBP )
● Exfactory Price: 1544.03 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 30
● Public Price: 1592 EUR ( 29,261,039.60 LBP )
● Pack size unit used: 30
● Cost/Unit: 53,0667 EUR ( 974,142.65 LBP )
● Reference: cbip
● Pricing Date: 02/12/2020
● Type: Medicine Authorised

● Country: Spain
● Package Size: 30
● Public Price: 693.04 EUR ( 12,738,109.85 LBP )
● Pack size unit used: 30
● Cost/Unit: 23,1013 EUR ( 422,741.15 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 30
● Public Price: 4968.69 TRY ( 9,543,313.20 LBP )
● Pack size unit used: 30
● Cost/Unit: 165,623 TRY ( 316,913.85 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Egypt
● Package Size: Boîte de 30
● Public Price: 9700 EGP ( 9,312,970.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 323,3333 EGP ( 310,112.30 LBP )
● Pricing Date: 02/12/2019
● Type: Medicine Authorised

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 30
● Public Price: 2255578 LBP ( 2,255,578.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 75185,93 LBP ( 75,185.00 LBP )
● Pricing Date: 10/01/2024

● Country: New Zealand
● Package Size: 30 tab
● Exfactory Price: 4555.76 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Portugal
● Package Size: 30
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019

● Country: Tunisia
● Package Size: Boîte de 30
● Public Price: 19914 TND ( 0.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 663,8 TND ( 0.00 LBP )
● Pricing Date: 04/02/2019
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 134,054 EUR ( 2,462,926.70 LBP )
● Cost/Day: 268,11 EUR ( 4,925,853.40 LBP )
● Cost/Month: 8043,3 EUR ( 147,830,742.15 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 134,054 EUR ( 2,462,926.70 LBP )
● Cost/Day: 268,11 EUR ( 4,925,853.40 LBP )
● Cost/Month: 8043,3 EUR ( 147,830,742.15 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 134,054 EUR ( 2,462,926.70 LBP )
● Cost/Day: 268,11 EUR ( 4,925,853.40 LBP )
● Cost/Month: 8043,3 EUR ( 147,830,742.15 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 134,054 EUR ( 2,462,926.70 LBP )
● Cost/Day: 268,11 EUR ( 4,925,853.40 LBP )
● Cost/Month: 8043,3 EUR ( 147,830,742.15 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 134,054 EUR ( 2,462,926.70 LBP )
● Cost/Day: 268,11 EUR ( 4,925,853.40 LBP )
● Cost/Month: 8043,3 EUR ( 147,830,742.15 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 573,7333 QAR ( 2,378,270.88 LBP )
● Cost/Day: 1147,47 QAR ( 4,760,692.32 LBP )
● Cost/Month: 34424,1 QAR ( 142,878,877.44 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 573,7333 QAR ( 2,378,270.88 LBP )
● Cost/Day: 1147,47 QAR ( 4,760,692.32 LBP )
● Cost/Month: 34424,1 QAR ( 142,878,877.44 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 573,7333 QAR ( 2,378,270.88 LBP )
● Cost/Day: 1147,47 QAR ( 4,760,692.32 LBP )
● Cost/Month: 34424,1 QAR ( 142,878,877.44 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 573,7333 QAR ( 2,378,270.88 LBP )
● Cost/Day: 1147,47 QAR ( 4,760,692.32 LBP )
● Cost/Month: 34424,1 QAR ( 142,878,877.44 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 573,7333 QAR ( 2,378,270.88 LBP )
● Cost/Day: 1147,47 QAR ( 4,760,692.32 LBP )
● Cost/Month: 34424,1 QAR ( 142,878,877.44 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 60,4083 OMR ( 2,358,030.00 LBP )
● Cost/Day: 120,82 OMR ( 4,716,060.00 LBP )
● Cost/Month: 3624,6 OMR ( 142,425,012.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 60,4083 OMR ( 2,358,030.00 LBP )
● Cost/Day: 120,82 OMR ( 4,716,060.00 LBP )
● Cost/Month: 3624,6 OMR ( 142,425,012.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 60,4083 OMR ( 2,358,030.00 LBP )
● Cost/Day: 120,82 OMR ( 4,716,060.00 LBP )
● Cost/Month: 3624,6 OMR ( 142,425,012.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 60,4083 OMR ( 2,358,030.00 LBP )
● Cost/Day: 120,82 OMR ( 4,716,060.00 LBP )
● Cost/Month: 3624,6 OMR ( 142,425,012.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 60,4083 OMR ( 2,358,030.00 LBP )
● Cost/Day: 120,82 OMR ( 4,716,060.00 LBP )
● Cost/Month: 3624,6 OMR ( 142,425,012.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 47,0713 KWD ( 2,329,793.76 LBP )
● Cost/Day: 94,14 KWD ( 4,659,587.52 LBP )
● Cost/Month: 2824,2 KWD ( 139,985,905.92 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 47,0713 KWD ( 2,329,793.76 LBP )
● Cost/Day: 94,14 KWD ( 4,659,587.52 LBP )
● Cost/Month: 2824,2 KWD ( 139,985,905.92 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 47,0713 KWD ( 2,329,793.76 LBP )
● Cost/Day: 94,14 KWD ( 4,659,587.52 LBP )
● Cost/Month: 2824,2 KWD ( 139,985,905.92 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 47,0713 KWD ( 2,329,793.76 LBP )
● Cost/Day: 94,14 KWD ( 4,659,587.52 LBP )
● Cost/Month: 2824,2 KWD ( 139,985,905.92 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 47,0713 KWD ( 2,329,793.76 LBP )
● Cost/Day: 94,14 KWD ( 4,659,587.52 LBP )
● Cost/Month: 2824,2 KWD ( 139,985,905.92 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 536,1167 AED ( 2,203,474.56 LBP )
● Cost/Day: 1072,23 AED ( 4,406,949.12 LBP )
● Cost/Month: 32166,9 AED ( 132,233,139.36 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 50,994 BHD ( 2,006,038.50 LBP )
● Cost/Day: 101,99 BHD ( 4,052,197.77 LBP )
● Cost/Month: 3059,7 BHD ( 122,729,435.43 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 50,994 BHD ( 2,006,038.50 LBP )
● Cost/Day: 101,99 BHD ( 4,052,197.77 LBP )
● Cost/Month: 3059,7 BHD ( 122,729,435.43 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 50,994 BHD ( 2,006,038.50 LBP )
● Cost/Day: 101,99 BHD ( 4,052,197.77 LBP )
● Cost/Month: 3059,7 BHD ( 122,729,435.43 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 50,994 BHD ( 2,006,038.50 LBP )
● Cost/Day: 101,99 BHD ( 4,052,197.77 LBP )
● Cost/Month: 3059,7 BHD ( 122,729,435.43 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 50,994 BHD ( 2,006,038.50 LBP )
● Cost/Day: 101,99 BHD ( 4,052,197.77 LBP )
● Cost/Month: 3059,7 BHD ( 122,729,435.43 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 491,005 SAR ( 1,978,916.58 LBP )
● Cost/Day: 982,01 SAR ( 3,957,833.16 LBP )
● Cost/Month: 29460,3 SAR ( 118,734,994.80 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 491,005 SAR ( 1,978,916.58 LBP )
● Cost/Day: 982,01 SAR ( 3,957,833.16 LBP )
● Cost/Month: 29460,3 SAR ( 118,734,994.80 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 491,005 SAR ( 1,978,916.58 LBP )
● Cost/Day: 982,01 SAR ( 3,957,833.16 LBP )
● Cost/Month: 29460,3 SAR ( 118,734,994.80 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 491,005 SAR ( 1,978,916.58 LBP )
● Cost/Day: 982,01 SAR ( 3,957,833.16 LBP )
● Cost/Month: 29460,3 SAR ( 118,734,994.80 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 491,005 SAR ( 1,978,916.58 LBP )
● Cost/Day: 982,01 SAR ( 3,957,833.16 LBP )
● Cost/Month: 29460,3 SAR ( 118,734,994.80 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 84,5233 JOD ( 1,792,575.96 LBP )
● Cost/Day: 169,05 JOD ( 3,606,492.11 LBP )
● Cost/Month: 5071,5 JOD ( 108,216,103.49 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 84,5233 JOD ( 1,792,575.96 LBP )
● Cost/Day: 169,05 JOD ( 3,606,492.11 LBP )
● Cost/Month: 5071,5 JOD ( 108,216,103.49 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 84,5233 JOD ( 1,792,575.96 LBP )
● Cost/Day: 169,05 JOD ( 3,606,492.11 LBP )
● Cost/Month: 5071,5 JOD ( 108,216,103.49 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 84,5233 JOD ( 1,792,575.96 LBP )
● Cost/Day: 169,05 JOD ( 3,606,492.11 LBP )
● Cost/Month: 5071,5 JOD ( 108,216,103.49 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 84,5233 JOD ( 1,792,575.96 LBP )
● Cost/Day: 169,05 JOD ( 3,606,492.11 LBP )
● Cost/Month: 5071,5 JOD ( 108,216,103.49 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 713,4533 DKK ( 1,754,671.61 LBP )
● Cost/Day: 1426,91 DKK ( 3,509,343.22 LBP )
● Cost/Month: 42807,3 DKK ( 105,346,742.79 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 713,4533 DKK ( 1,754,671.61 LBP )
● Cost/Day: 1426,91 DKK ( 3,509,343.22 LBP )
● Cost/Month: 42807,3 DKK ( 105,346,742.79 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 713,4533 DKK ( 1,754,671.61 LBP )
● Cost/Day: 1426,91 DKK ( 3,509,343.22 LBP )
● Cost/Month: 42807,3 DKK ( 105,346,742.79 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 713,4533 DKK ( 1,754,671.61 LBP )
● Cost/Day: 1426,91 DKK ( 3,509,343.22 LBP )
● Cost/Month: 42807,3 DKK ( 105,346,742.79 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 713,4533 DKK ( 1,754,671.61 LBP )
● Cost/Day: 1426,91 DKK ( 3,509,343.22 LBP )
● Cost/Month: 42807,3 DKK ( 105,346,742.79 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 95,221 EUR ( 1,746,104.75 LBP )
● Cost/Day: 190,44 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5713,2 EUR ( 105,005,225.65 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 95,221 EUR ( 1,746,104.75 LBP )
● Cost/Day: 190,44 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5713,2 EUR ( 105,005,225.65 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 95,221 EUR ( 1,746,104.75 LBP )
● Cost/Day: 190,44 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5713,2 EUR ( 105,005,225.65 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 95,221 EUR ( 1,746,104.75 LBP )
● Cost/Day: 190,44 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5713,2 EUR ( 105,005,225.65 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 95,221 EUR ( 1,746,104.75 LBP )
● Cost/Day: 190,44 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5713,2 EUR ( 105,005,225.65 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 93,673 EUR ( 1,709,344.65 LBP )
● Cost/Day: 187,35 EUR ( 3,437,069.35 LBP )
● Cost/Month: 5620,5 EUR ( 103,295,881.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 93,673 EUR ( 1,709,344.65 LBP )
● Cost/Day: 187,35 EUR ( 3,437,069.35 LBP )
● Cost/Month: 5620,5 EUR ( 103,295,881.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 93,673 EUR ( 1,709,344.65 LBP )
● Cost/Day: 187,35 EUR ( 3,437,069.35 LBP )
● Cost/Month: 5620,5 EUR ( 103,295,881.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 93,673 EUR ( 1,709,344.65 LBP )
● Cost/Day: 187,35 EUR ( 3,437,069.35 LBP )
● Cost/Month: 5620,5 EUR ( 103,295,881.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 93,673 EUR ( 1,709,344.65 LBP )
● Cost/Day: 187,35 EUR ( 3,437,069.35 LBP )
● Cost/Month: 5620,5 EUR ( 103,295,881.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 86,4907 EUR ( 1,580,684.30 LBP )
● Cost/Day: 172,98 EUR ( 3,161,368.60 LBP )
● Cost/Month: 5189,4 EUR ( 95,374,079.45 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 86,4907 EUR ( 1,580,684.30 LBP )
● Cost/Day: 172,98 EUR ( 3,161,368.60 LBP )
● Cost/Month: 5189,4 EUR ( 95,374,079.45 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 86,4907 EUR ( 1,580,684.30 LBP )
● Cost/Day: 172,98 EUR ( 3,161,368.60 LBP )
● Cost/Month: 5189,4 EUR ( 95,374,079.45 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 86,4907 EUR ( 1,580,684.30 LBP )
● Cost/Day: 172,98 EUR ( 3,161,368.60 LBP )
● Cost/Month: 5189,4 EUR ( 95,374,079.45 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 86,4907 EUR ( 1,580,684.30 LBP )
● Cost/Day: 172,98 EUR ( 3,161,368.60 LBP )
● Cost/Month: 5189,4 EUR ( 95,374,079.45 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 13885,2 ISK ( 1,539,291.10 LBP )
● Cost/Day: 27770,4 ISK ( 3,078,582.20 LBP )
● Cost/Month: 833112 ISK ( 92,358,796.32 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 13885,2 ISK ( 1,539,291.10 LBP )
● Cost/Day: 27770,4 ISK ( 3,078,582.20 LBP )
● Cost/Month: 833112 ISK ( 92,358,796.32 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 13885,2 ISK ( 1,539,291.10 LBP )
● Cost/Day: 27770,4 ISK ( 3,078,582.20 LBP )
● Cost/Month: 833112 ISK ( 92,358,796.32 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 13885,2 ISK ( 1,539,291.10 LBP )
● Cost/Day: 27770,4 ISK ( 3,078,582.20 LBP )
● Cost/Month: 833112 ISK ( 92,358,796.32 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 13885,2 ISK ( 1,539,291.10 LBP )
● Cost/Day: 27770,4 ISK ( 3,078,582.20 LBP )
● Cost/Month: 833112 ISK ( 92,358,796.32 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 75 GBP ( 1,511,307.75 LBP )
● Cost/Day: 150 GBP ( 3,022,615.50 LBP )
● Cost/Month: 4500 GBP ( 90,678,465.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 75 GBP ( 1,511,307.75 LBP )
● Cost/Day: 150 GBP ( 3,022,615.50 LBP )
● Cost/Month: 4500 GBP ( 90,678,465.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 75 GBP ( 1,511,307.75 LBP )
● Cost/Day: 150 GBP ( 3,022,615.50 LBP )
● Cost/Month: 4500 GBP ( 90,678,465.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 75 GBP ( 1,511,307.75 LBP )
● Cost/Day: 150 GBP ( 3,022,615.50 LBP )
● Cost/Month: 4500 GBP ( 90,678,465.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 75 GBP ( 1,511,307.75 LBP )
● Cost/Day: 150 GBP ( 3,022,615.50 LBP )
● Cost/Month: 4500 GBP ( 90,678,465.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 823,811 SEK ( 1,481,490.53 LBP )
● Cost/Day: 1647,62 SEK ( 2,964,781.17 LBP )
● Cost/Month: 49428,6 SEK ( 88,975,837.08 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 823,811 SEK ( 1,481,490.53 LBP )
● Cost/Day: 1647,62 SEK ( 2,964,781.17 LBP )
● Cost/Month: 49428,6 SEK ( 88,975,837.08 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 823,811 SEK ( 1,481,490.53 LBP )
● Cost/Day: 1647,62 SEK ( 2,964,781.17 LBP )
● Cost/Month: 49428,6 SEK ( 88,975,837.08 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 823,811 SEK ( 1,481,490.53 LBP )
● Cost/Day: 1647,62 SEK ( 2,964,781.17 LBP )
● Cost/Month: 49428,6 SEK ( 88,975,837.08 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 823,811 SEK ( 1,481,490.53 LBP )
● Cost/Day: 1647,62 SEK ( 2,964,781.17 LBP )
● Cost/Month: 49428,6 SEK ( 88,975,837.08 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 848,7033 NOK ( 1,467,268.96 LBP )
● Cost/Day: 1697,41 NOK ( 2,936,268.19 LBP )
● Cost/Month: 50922,3 NOK ( 88,108,808.94 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 848,7033 NOK ( 1,467,268.96 LBP )
● Cost/Day: 1697,41 NOK ( 2,936,268.19 LBP )
● Cost/Month: 50922,3 NOK ( 88,108,808.94 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 848,7033 NOK ( 1,467,268.96 LBP )
● Cost/Day: 1697,41 NOK ( 2,936,268.19 LBP )
● Cost/Month: 50922,3 NOK ( 88,108,808.94 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 848,7033 NOK ( 1,467,268.96 LBP )
● Cost/Day: 1697,41 NOK ( 2,936,268.19 LBP )
● Cost/Month: 50922,3 NOK ( 88,108,808.94 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 848,7033 NOK ( 1,467,268.96 LBP )
● Cost/Day: 1697,41 NOK ( 2,936,268.19 LBP )
● Cost/Month: 50922,3 NOK ( 88,108,808.94 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 79,553 EUR ( 1,452,023.95 LBP )
● Cost/Day: 159,11 EUR ( 2,922,427.95 LBP )
● Cost/Month: 4773,3 EUR ( 87,727,978.65 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 79,553 EUR ( 1,452,023.95 LBP )
● Cost/Day: 159,11 EUR ( 2,922,427.95 LBP )
● Cost/Month: 4773,3 EUR ( 87,727,978.65 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 79,553 EUR ( 1,452,023.95 LBP )
● Cost/Day: 159,11 EUR ( 2,922,427.95 LBP )
● Cost/Month: 4773,3 EUR ( 87,727,978.65 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 79,553 EUR ( 1,452,023.95 LBP )
● Cost/Day: 159,11 EUR ( 2,922,427.95 LBP )
● Cost/Month: 4773,3 EUR ( 87,727,978.65 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 79,553 EUR ( 1,452,023.95 LBP )
● Cost/Day: 159,11 EUR ( 2,922,427.95 LBP )
● Cost/Month: 4773,3 EUR ( 87,727,978.65 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 75,6373 EUR ( 1,378,503.75 LBP )
● Cost/Day: 151,27 EUR ( 2,775,387.55 LBP )
● Cost/Month: 4538,1 EUR ( 83,408,666.90 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 75,6373 EUR ( 1,378,503.75 LBP )
● Cost/Day: 151,27 EUR ( 2,775,387.55 LBP )
● Cost/Month: 4538,1 EUR ( 83,408,666.90 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 75,6373 EUR ( 1,378,503.75 LBP )
● Cost/Day: 151,27 EUR ( 2,775,387.55 LBP )
● Cost/Month: 4538,1 EUR ( 83,408,666.90 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 75,6373 EUR ( 1,378,503.75 LBP )
● Cost/Day: 151,27 EUR ( 2,775,387.55 LBP )
● Cost/Month: 4538,1 EUR ( 83,408,666.90 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 75,6373 EUR ( 1,378,503.75 LBP )
● Cost/Day: 151,27 EUR ( 2,775,387.55 LBP )
● Cost/Month: 4538,1 EUR ( 83,408,666.90 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 1922,8843 CZK ( 1,327,640.72 LBP )
● Cost/Day: 3845,77 CZK ( 2,655,972.20 LBP )
● Cost/Month: 115373,1 CZK ( 79,695,053.48 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 1922,8843 CZK ( 1,327,640.72 LBP )
● Cost/Day: 3845,77 CZK ( 2,655,972.20 LBP )
● Cost/Month: 115373,1 CZK ( 79,695,053.48 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 1922,8843 CZK ( 1,327,640.72 LBP )
● Cost/Day: 3845,77 CZK ( 2,655,972.20 LBP )
● Cost/Month: 115373,1 CZK ( 79,695,053.48 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 1922,8843 CZK ( 1,327,640.72 LBP )
● Cost/Day: 3845,77 CZK ( 2,655,972.20 LBP )
● Cost/Month: 115373,1 CZK ( 79,695,053.48 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 1922,8843 CZK ( 1,327,640.72 LBP )
● Cost/Day: 3845,77 CZK ( 2,655,972.20 LBP )
● Cost/Month: 115373,1 CZK ( 79,695,053.48 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 63,975 EUR ( 1,157,943.15 LBP )
● Cost/Day: 127,95 EUR ( 2,334,266.35 LBP )
● Cost/Month: 3838,5 EUR ( 70,542,631.90 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 63,975 EUR ( 1,157,943.15 LBP )
● Cost/Day: 127,95 EUR ( 2,334,266.35 LBP )
● Cost/Month: 3838,5 EUR ( 70,542,631.90 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 63,975 EUR ( 1,157,943.15 LBP )
● Cost/Day: 127,95 EUR ( 2,334,266.35 LBP )
● Cost/Month: 3838,5 EUR ( 70,542,631.90 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 63,975 EUR ( 1,157,943.15 LBP )
● Cost/Day: 127,95 EUR ( 2,334,266.35 LBP )
● Cost/Month: 3838,5 EUR ( 70,542,631.90 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 63,975 EUR ( 1,157,943.15 LBP )
● Cost/Day: 127,95 EUR ( 2,334,266.35 LBP )
● Cost/Month: 3838,5 EUR ( 70,542,631.90 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 62,1637 EUR ( 1,139,563.10 LBP )
● Cost/Day: 124,33 EUR ( 2,279,126.20 LBP )
● Cost/Month: 3729,9 EUR ( 68,539,206.45 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 62,1637 EUR ( 1,139,563.10 LBP )
● Cost/Day: 124,33 EUR ( 2,279,126.20 LBP )
● Cost/Month: 3729,9 EUR ( 68,539,206.45 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 62,1637 EUR ( 1,139,563.10 LBP )
● Cost/Day: 124,33 EUR ( 2,279,126.20 LBP )
● Cost/Month: 3729,9 EUR ( 68,539,206.45 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 62,1637 EUR ( 1,139,563.10 LBP )
● Cost/Day: 124,33 EUR ( 2,279,126.20 LBP )
● Cost/Month: 3729,9 EUR ( 68,539,206.45 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 62,1637 EUR ( 1,139,563.10 LBP )
● Cost/Day: 124,33 EUR ( 2,279,126.20 LBP )
● Cost/Month: 3729,9 EUR ( 68,539,206.45 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 58,4967 CHF ( 989,494.50 LBP )
● Cost/Day: 116,99 CHF ( 1,978,989.00 LBP )
● Cost/Month: 3509,7 CHF ( 59,864,417.25 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 58,4967 CHF ( 989,494.50 LBP )
● Cost/Day: 116,99 CHF ( 1,978,989.00 LBP )
● Cost/Month: 3509,7 CHF ( 59,864,417.25 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 58,4967 CHF ( 989,494.50 LBP )
● Cost/Day: 116,99 CHF ( 1,978,989.00 LBP )
● Cost/Month: 3509,7 CHF ( 59,864,417.25 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 58,4967 CHF ( 989,494.50 LBP )
● Cost/Day: 116,99 CHF ( 1,978,989.00 LBP )
● Cost/Month: 3509,7 CHF ( 59,864,417.25 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 58,4967 CHF ( 989,494.50 LBP )
● Cost/Day: 116,99 CHF ( 1,978,989.00 LBP )
● Cost/Month: 3509,7 CHF ( 59,864,417.25 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 53,0667 EUR ( 974,142.65 LBP )
● Cost/Day: 106,13 EUR ( 1,948,285.30 LBP )
● Cost/Month: 3183,9 EUR ( 58,503,699.15 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 53,0667 EUR ( 974,142.65 LBP )
● Cost/Day: 106,13 EUR ( 1,948,285.30 LBP )
● Cost/Month: 3183,9 EUR ( 58,503,699.15 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 53,0667 EUR ( 974,142.65 LBP )
● Cost/Day: 106,13 EUR ( 1,948,285.30 LBP )
● Cost/Month: 3183,9 EUR ( 58,503,699.15 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 53,0667 EUR ( 974,142.65 LBP )
● Cost/Day: 106,13 EUR ( 1,948,285.30 LBP )
● Cost/Month: 3183,9 EUR ( 58,503,699.15 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 53,0667 EUR ( 974,142.65 LBP )
● Cost/Day: 106,13 EUR ( 1,948,285.30 LBP )
● Cost/Month: 3183,9 EUR ( 58,503,699.15 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 23,1013 EUR ( 422,741.15 LBP )
● Cost/Day: 46,2 EUR ( 845,482.30 LBP )
● Cost/Month: 1386 EUR ( 25,474,749.30 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 23,1013 EUR ( 422,741.15 LBP )
● Cost/Day: 46,2 EUR ( 845,482.30 LBP )
● Cost/Month: 1386 EUR ( 25,474,749.30 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 23,1013 EUR ( 422,741.15 LBP )
● Cost/Day: 46,2 EUR ( 845,482.30 LBP )
● Cost/Month: 1386 EUR ( 25,474,749.30 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 23,1013 EUR ( 422,741.15 LBP )
● Cost/Day: 46,2 EUR ( 845,482.30 LBP )
● Cost/Month: 1386 EUR ( 25,474,749.30 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 23,1013 EUR ( 422,741.15 LBP )
● Cost/Day: 46,2 EUR ( 845,482.30 LBP )
● Cost/Month: 1386 EUR ( 25,474,749.30 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 165,623 TRY ( 316,913.85 LBP )
● Cost/Day: 331,25 TRY ( 635,748.39 LBP )
● Cost/Month: 9937,5 TRY ( 19,085,896.53 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 165,623 TRY ( 316,913.85 LBP )
● Cost/Day: 331,25 TRY ( 635,748.39 LBP )
● Cost/Month: 9937,5 TRY ( 19,085,896.53 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 165,623 TRY ( 316,913.85 LBP )
● Cost/Day: 331,25 TRY ( 635,748.39 LBP )
● Cost/Month: 9937,5 TRY ( 19,085,896.53 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 165,623 TRY ( 316,913.85 LBP )
● Cost/Day: 331,25 TRY ( 635,748.39 LBP )
● Cost/Month: 9937,5 TRY ( 19,085,896.53 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 165,623 TRY ( 316,913.85 LBP )
● Cost/Day: 331,25 TRY ( 635,748.39 LBP )
● Cost/Month: 9937,5 TRY ( 19,085,896.53 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 323,3333 EGP ( 310,112.30 LBP )
● Cost/Day: 646,67 EGP ( 620,224.60 LBP )
● Cost/Month: 19400,1 EGP ( 18,625,940.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 323,3333 EGP ( 310,112.30 LBP )
● Cost/Day: 646,67 EGP ( 620,224.60 LBP )
● Cost/Month: 19400,1 EGP ( 18,625,940.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 323,3333 EGP ( 310,112.30 LBP )
● Cost/Day: 646,67 EGP ( 620,224.60 LBP )
● Cost/Month: 19400,1 EGP ( 18,625,940.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 323,3333 EGP ( 310,112.30 LBP )
● Cost/Day: 646,67 EGP ( 620,224.60 LBP )
● Cost/Month: 19400,1 EGP ( 18,625,940.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 323,3333 EGP ( 310,112.30 LBP )
● Cost/Day: 646,67 EGP ( 620,224.60 LBP )
● Cost/Month: 19400,1 EGP ( 18,625,940.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 75185,93 LBP ( 75,185.00 LBP )
● Cost/Day: 150371,86 LBP ( 150,371.00 LBP )
● Cost/Month: 4511155,8 LBP ( 4,511,155.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 75185,93 LBP ( 75,185.00 LBP )
● Cost/Day: 150371,86 LBP ( 150,371.00 LBP )
● Cost/Month: 4511155,8 LBP ( 4,511,155.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 75185,93 LBP ( 75,185.00 LBP )
● Cost/Day: 150371,86 LBP ( 150,371.00 LBP )
● Cost/Month: 4511155,8 LBP ( 4,511,155.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 75185,93 LBP ( 75,185.00 LBP )
● Cost/Day: 150371,86 LBP ( 150,371.00 LBP )
● Cost/Month: 4511155,8 LBP ( 4,511,155.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 75185,93 LBP ( 75,185.00 LBP )
● Cost/Day: 150371,86 LBP ( 150,371.00 LBP )
● Cost/Month: 4511155,8 LBP ( 4,511,155.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 663,8 TND ( 0.00 LBP )
● Cost/Day: 1327,6 TND ( 0.00 LBP )
● Cost/Month: 39828 TND ( 0.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 663,8 TND ( 0.00 LBP )
● Cost/Day: 1327,6 TND ( 0.00 LBP )
● Cost/Month: 39828 TND ( 0.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 663,8 TND ( 0.00 LBP )
● Cost/Day: 1327,6 TND ( 0.00 LBP )
● Cost/Month: 39828 TND ( 0.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 663,8 TND ( 0.00 LBP )
● Cost/Day: 1327,6 TND ( 0.00 LBP )
● Cost/Month: 39828 TND ( 0.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 663,8 TND ( 0.00 LBP )
● Cost/Day: 1327,6 TND ( 0.00 LBP )
● Cost/Month: 39828 TND ( 0.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info